Literature DB >> 12525837

Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.

T Kanazawa1, H Mizukami, T Okada, Y Hanazono, A Kume, H Nishino, K Takeuchi, K Kitamura, K Ichimura, K Ozawa.   

Abstract

The application of adeno-associated virus (AAV) vectors to cancers is limited by their low transduction efficiency. Previously, we reported that gamma-ray enhanced the second-strand synthesis, leading to the improvement of the transgene expression, and cytocidal effect of the herpes simplex virus type-1 thymidine kinase (HSVtk) and ganciclovir (GCV) system. In this study, we extended this in vitro findings to in vivo. First, the laryngeal cancer cell line (HEp-2) and HeLa were treated with AAVtk/GCV, the number of surviving cells was reduced as the concentration of GCV increased. Furthermore, the 4 Gy irradiation enhanced the killing effects of AAVtk/GCV by four-fold on HeLa cells and 15-fold on HEp-2 cells. Following the in vitro experiments, we evaluated the transgene expression and the antitumor activity of the AAV vectors in combination with gamma-ray in nude mice inoculated with HEp-2 subcutaneously. The LacZ expression was observed in the xenografted tumors and significantly increased by gamma-ray. The AAVtk/GCV system suppressed the tumors growth, and gamma-ray augmented the antitumor activity by five-fold. These findings suggest that the combination of AAVtk/GCV system with radiotherapy is significantly effective in the treatment of cancers and may lead to reduction of the potential toxicity of both AAVtk/GCV and gamma-ray.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525837     DOI: 10.1038/sj.gt.3301837

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  12 in total

Review 1.  Adeno-associated virus-mediated cancer gene therapy: current status.

Authors:  Jingfeng Luo; Yuxuan Luo; Jihong Sun; Yurong Zhou; Yajing Zhang; Xiaoming Yang
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

Review 2.  Treatment of human disease by adeno-associated viral gene transfer.

Authors:  Kenneth H Warrington; Roland W Herzog
Journal:  Hum Genet       Date:  2006-04-13       Impact factor: 4.132

Review 3.  Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.

Authors:  Yan-Xia Mi; Ya-Hong Long; Yun-Chun Li
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

Review 4.  Vector engineering, strategies and targets in cancer gene therapy.

Authors:  Vijayata Singh; Nusrat Khan; Giridhara R Jayandharan
Journal:  Cancer Gene Ther       Date:  2021-04-15       Impact factor: 5.987

Review 5.  Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy.

Authors:  Spencer J Collis; Kevin Khater; Theodore L DeWeese
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 3.661

6.  Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.

Authors:  Minghong Jiang; Zheng Liu; Yang Xiang; Hong Ma; Shilian Liu; Yanxin Liu; Dexian Zheng
Journal:  BMC Cancer       Date:  2011-02-03       Impact factor: 4.430

7.  Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma.

Authors:  Hong Ma; Yunjia Zhang; Hailong Wang; Chuanhui Han; Runhong Lei; Lei Zhang; Zuye Yang; Ling Rao; Hong Qing; Jim Xiang; Yulin Deng
Journal:  Int J Mol Sci       Date:  2013-12-19       Impact factor: 5.923

8.  Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma.

Authors:  Sha-Sha He; Qin-Jie Wu; Chang Yang Gong; Shun-Tao Luo; Shuang Zhang; Meng Li; Lian Lu; Yu-Quan Wei; Li Yang
Journal:  Mol Med Rep       Date:  2014-04-04       Impact factor: 2.952

9.  Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.

Authors:  Takayuki Uehara; Takeharu Kanazawa; Hiroaki Mizukami; Ryosuke Uchibori; Tomonori Tsukahara; Masashi Urabe; Akihiro Kume; Kiyoshi Misawa; Thomas E Carey; Mikio Suzuki; Keiichi Ichimura; Keiya Ozawa
Journal:  Cancer Sci       Date:  2013-12-01       Impact factor: 6.716

Review 10.  G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?

Authors:  Takeharu Kanazawa; Kiyoshi Misawa; Yuki Misawa; Takayuki Uehara; Hirofumi Fukushima; Gen Kusaka; Mikiko Maruta; Thomas E Carey
Journal:  Toxins (Basel)       Date:  2015-08-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.